Valeo Pharma Inc. (VPHIF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 53.91 Million | 27.74 Million | 13.55 Million | 7.47 Million | 6.57 Million | 4.38 Million |
| Cost of Revenue | 40.83 Million | 21.46 Million | 9.6 Million | 6.08 Million | 5.17 Million | 3.54 Million |
| Gross Profit | 13.07 Million | 6.28 Million | 3.95 Million | 1.38 Million | 1.4 Million | 832.96 Thousand |
| Operating Expenses | 31.81 Million | 25.39 Million | 16.64 Million | 5.68 Million | 5.13 Million | 3.26 Million |
| Selling, General and Administrative Expenses | 29.15 Million | 24.9 Million | 16.19 Million | 5.44 Million | 5.05 Million | 3.21 Million |
| Research and Development Expenses | - | - | - | - | 8000.00 | - |
| Other Expenses | 1.15 Million | - | 123 Thousand | 198 Thousand | 253 Thousand | 147.03 Thousand |
| Cost and Expenses | 71.13 Million | 46.85 Million | 26.25 Million | 11.77 Million | 10.31 Million | 6.81 Million |
| Operating Income | -17.22 Million | -19.6 Million | -12.94 Million | -4.11 Million | -3.54 Million | -2.37 Million |
| Interest Expense | 13.79 Million | 6.46 Million | 1.35 Million | 598 Thousand | 110 Thousand | 173.84 Thousand |
| Income Tax Expense | - | -1.17 Million | 1.47 Million | 796 Thousand | 326 Thousand | 36.71 Thousand |
| Earnings before Tax | -27.8 Million | -26.92 Million | -14.23 Million | -4.76 Million | -3.61 Million | -2.4 Million |
| Net Income | -27.8 Million | -25.74 Million | -14.23 Million | -4.76 Million | -3.61 Million | -2.43 Million |
| Earnings Per Share Basic | -0.32 | -0.32 | -0.20 | -0.08 | -0.07 | -0.05 |
| Earnings Per Share Diluted | -0.32 | -0.32 | -0.20 | -0.08 | -0.07 | -0.05 |
| Weighted Average Shares Outstanding | 86.11 Million | 80.85 Million | 69.93 Million | 57.9 Million | 49.58 Million | 48.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 86.11 Million | 80.85 Million | 69.93 Million | 57.9 Million | 49.58 Million | 48.47 Million |
| Gross Margin | 0.24 | 0.23 | 0.29 | 0.18 | 0.21 | 0.19 |
| EBIT Margin | -0.21 | -0.63 | -0.87 | -0.49 | -0.52 | -0.53 |
| Profit Margin | -0.52 | -0.93 | -1.05 | -0.64 | -0.55 | -0.56 |
| EBITDA | -11.39 Million | -17.55 Million | -11.85 Million | -3.73 Million | -3.41 Million | -2.32 Million |
| Earnings Before Tax Margin | -0.32 | -0.71 | -0.95 | -0.55 | -0.54 | -0.54 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 12.6 Million | 14.12 Million | 13.53 Million | 53.91 Million | 13.1 Million | 14.08 Million |
| Cost of Revenue | 9.56 Million | 11.38 Million | 11.43 Million | 40.83 Million | 12.47 Million | 9.81 Million |
| Gross Profit | 3.03 Million | 2.74 Million | 2.1 Million | 13.07 Million | 632 Thousand | 4.27 Million |
| Operating Expenses | 6.25 Million | 6.63 Million | 6.96 Million | 30.3 Million | 7.76 Million | 7.7 Million |
| Selling, General and Administrative Expenses | 6.12 Million | 6.63 Million | 6.96 Million | - | 7.35 Million | 7.41 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 2 Million | - | - | - | - | - |
| Cost and Expenses | 15.82 Million | 18.02 Million | 18.4 Million | 71.13 Million | 20.24 Million | 17.51 Million |
| Operating Income | -3.22 Million | -3.89 Million | -4.86 Million | -17.22 Million | -7.13 Million | -3.43 Million |
| Interest Expense | 3.88 Million | 3.84 Million | 3.74 Million | 13.79 Million | 3.75 Million | 3.45 Million |
| Income Tax Expense | 3.88 Million | - | 608.72 Thousand | 13.79 Million | 3.75 Million | 3.45 Million |
| Earnings before Tax | -8.19 Million | -7.81 Million | -6.87 Million | -27.8 Million | -9.24 Million | -5.83 Million |
| Net Income | -8.19 Million | -7.81 Million | -6.87 Million | -27.8 Million | -9.24 Million | -5.83 Million |
| Earnings Per Share Basic | -0.08 | -0.08 | -0.08 | - | -0.10 | -0.07 |
| Earnings Per Share Diluted | -0.08 | -0.08 | -0.08 | - | -0.10 | -0.07 |
| Weighted Average Shares Outstanding | 98.67 Million | 98.67 Million | 86.13 Million | 86.11 Million | 94.01 Million | 84.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 98.67 Million | 98.67 Million | 86.13 Million | 86.11 Million | 94.01 Million | 84.47 Million |
| Gross Margin | 0.24 | 0.19 | 0.16 | 0.24 | 0.05 | 0.30 |
| EBIT Margin | -0.20 | -0.23 | -0.31 | - | -0.21 | -0.20 |
| Profit Margin | -0.65 | -0.55 | -0.51 | -0.52 | -0.71 | -0.41 |
| EBITDA | -2.58 Million | -3.25 Million | -4.21 Million | - | -2.77 Million | -2.77 Million |
| Earnings Before Tax Margin | -0.26 | -0.28 | -0.36 | -0.32 | -0.54 | -0.24 |
VNUE
PTMP
688670
VSBGF
NTLA
6698